4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-23-000005
Options or other derivatives
- Chief Scientific Officer acquired 180,995 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duffield Jeremy Chief Scientific Officer | 2023-03-31 | Grant or award · Stock Option (right to buy) | +180,995 | 180,995 | D | ||
Loading xslF345X04/wf-form4_168065417838934.xml…